Abstract:In an ongoing investigation of 20-sulfonylamidine derivatives (9, YQL-9a) of camptothecin (1) as potential anticancer agents directly and selectively inhibiting topoisomerase (Topo) I, the sulfonylamidine pharmacophore was held constant, and a camptothecin derivatives with various substitution patterns were synthesized. The new compounds were evaluated for antiproliferative activity against three human tumor cell lines, A-549, KB, and multidrug resistant (MDR) KB subline (KBvin). Several analogs showed comparable or superior antiproliferative activity compared to the clinically prescribed 1 and irinotecan (3). Significantly, the 20-sulfonylamidine derivatives exhibited comparable cytotoxicity against KBvin, while 1 and 3 were less active against this cell line. Among them, compound 15c displayed much better cytotoxic activity than the controls 1, 3, and 9. Novel key structural features related to the antiproliferative activities were identified by structure-activity relationship (SAR) analysis. In a molecular docking model, compounds 9 and 15c interacted with Topo I-DNA through a different binding mode from 1 and 3. The sulfonylamidine side chains of 9 and 15c could likely form direct hydrogen bonds with Topo I, while hydrophobic interaction with Topo I and π-π stacking with double strand DNA were also confirmed as binding driving forces. The results from docking models were consistent with the SAR conclusions. The introduction of bulky substituents at the 20-position contributed to the altered binding mode of the compound by allowing them to form new interactions with Topo I residues. The information obtained in this study will be helpful for the design of new derivatives of 1 with most promising anticancer activity.

Design, synthesis and cytotoxicity of novel 3'-N-alkoxycarbonyl docetaxel analogs.

Design, Synthesis and Biological Evaluation of Novel Fluorinated Docetaxel Analogues.

Design, Synthesis, Mechanisms of Action, and Toxicity of Novel 20(S)-Sulfonylamidine Derivatives of Camptothecin As Potent Antitumor Agents

Synthesis, cytotoxicity, metabolic stability and pharmacokinetic evaluation of fluorinated docetaxel analogs.

Synthesis, Cytotoxic Activity and Binding Model Analysis of Novel Isoxazole-Docetaxel Analogues with C3′- N Modification

Synthesis and anticancer activity of novel quinoline-docetaxel analogues.

Design, Synthesis, Cytotoxic Activity and Molecular Docking Studies of New 20(S)-Sulfonylamidine Camptothecin Derivatives

Design and One-Pot Synthesis of New 7-Acyl Camptothecin Derivatives As Potent Cytotoxic Agents

Design and Synthesis of New 7-(N-substituted-methyl)-camptothecin Derivatives As Potent Cytotoxic Agents.

Design of Β-Carboline Derivatives As DNA-targeting Antitumor Agents

A Novel Docetaxel Derivative Exhibiting Potent Anti-Tumor Activity and High Safety in Preclinical Animal Models.

Synthesis and Biological Evaluation of Novel Larotaxel Analogues.

Discovery of Novel Heteroarylmethylcarbamodithioates As Potent Anticancer Agents: Synthesis, Structure-Activity Relationship Analysis and Biological Evaluation.

Design and Synthesis of Novel Spin-Labeled Camptothecin Derivatives As Potent Cytotoxic Agents.

Design, Synthesis and Biological Evaluation of N-arylsulfonyl Carbazoles As Novel Anticancer Agents

Synthesis and preliminary bioevaluation of novel E-ring modified acetal analog of camptothecin as cytotoxic agents.

Design, synthesis and potent cytotoxic activity of novel 7-(N-[(substituted-sulfonyl)piperazinyl]-methyl)-camptothecin derivatives.

Design, synthesis and antitumor activity of novel 4-oxobutanamide derivatives

Synthesis and Antitumor Activity of Novel 20S-Camptothecin Analogues

Structural diversity-guided optimization of carbazole derivatives as potential cytotoxic agents

Design, synthesis and anti-tumor activity of novel 5-amino-2-(benzylthio) thia-zole-4-carboxamide derivatives